Asset icon - trade crypto, stocks, and gold on Pluang
Trade on Pluang
One platform for all markets
Download

MKSI beats Q1 earnings with 15% revenue growth; new Malaysia facility to boost capacity by 2026

Company Fundamentals
16 May 2026
Seeking Alpha
View Source
Bullish
pluang ai news

MKSI Inc. reported a strong Q1 FY2026 earnings beat, with revenue rising 15% year-over-year and earnings per share up 35%, surpassing analyst expectations. Management highlighted a potential increase in wafer fab equipment (WFE) spending to $170-180 billion in 2027, positioning MKSI as a key supplier with significant growth opportunities. The company is expanding its production capacity with a new $100 million, 500,000 sq. ft. facility in Malaysia, expected to be operational by June 2026, supporting long-term growth and customer demand. Despite trading at a discount to peers with a 25.8x FY2026 price-to-earnings ratio, MKSI benefits from strong market catalysts including opportunities in LEO PCB and optical equipment sectors.

More News

NextEra and Dominion plan $400B merger to meet soaring AI-driven electricity demand.

NextEra and Dominion plan $400B merger to meet soaring AI-driven electricity demand.

NextEra Energy and Dominion Energy are in talks to merge in a deal valued around $400 billion, creating one of the largest utility companies in the U.S. This merger aims to address the rapidly growing electricity demand driven by AI data centers, ind...

Company Fundamentals
Neutral
49 minutes ago
Trump team ordered to discard all items from China on Air Force One amid spy fears

Trump team ordered to discard all items from China on Air Force One amid spy fears

During President Trump's summit with Chinese President Xi Jinping, U.S. officials aboard Air Force One were instructed to discard all items received in China, including burner phones, badges, and lapel pins. This precaution addresses concerns over Ch...

Market News
Neutral
2 hours ago
Royalty Pharma reports strong Q1 growth with 10% revenue rise and bullish outlook to 2030 targets.

Royalty Pharma reports strong Q1 growth with 10% revenue rise and bullish outlook to 2030 targets.

Royalty Pharma posted a 10% increase in Receipts to $925 million and a 13% rise in Royalty Receipts to $887 million in Q1, confirming strong broad-based momentum. The company’s management views the 2030 target of $4.7 billion in Portfolio Receipts as...

Company Fundamentals
Bullish
4 hours ago
US 30-year Treasury yields hit 5.12%, highest since 2007, amid global bond sell-off and UK debt concerns.

US 30-year Treasury yields hit 5.12%, highest since 2007, amid global bond sell-off and UK debt concerns.

US 30-year Treasury bond yields surged 18 basis points to 5.12%, reaching levels not seen since July 2007, surpassing spikes from the 2023 gilt crisis. This rise reflects a global bond market sell-off and growing concerns over the UK's government deb...

Market News
Bearish
4 hours ago
Trip.com faces a major antitrust probe by SAMR, causing a 40% stock drop amid potential hefty fines.

Trip.com faces a major antitrust probe by SAMR, causing a 40% stock drop amid potential hefty fines.

Trip.com Group is under investigation by China's State Administration for Market Regulation (SAMR) for alleged monopolistic practices, triggered by complaints from small hotel operators. This probe has led to a sharp 40% decline in Trip.com's stock p...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App